BackZivo Bioscience- Warrants (29/04/2026) Overview

Zivo Bioscience- Warrants (29/04/2026) Current Cash

Zivo Bioscience- Warrants (29/04/2026)'s current cash is $110K.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$113795.00
1058.45% YoYΔ $103972.00 vs prior year quarter

Peer trimmed avg / median

Loading

Zivo Bioscience- Warrants (29/04/2026) Current Cash History

Loading

Zivo Bioscience- Warrants (29/04/2026) vs. peers: Current Cash Comparison

Loading

Zivo Bioscience- Warrants (29/04/2026) Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Zivo Bioscience- Warrants (29/04/2026) (ZIVOW) FAQ

As of the most recent data (June 2026), ZIVOW shows a current cash of $110K. That compares with $9.8K in the prior-year period — up 1058.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ZIVOW's current cash is now $110K (was $9.8K) — a 1058.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Zivo Bioscience- Warrants (29/04/2026) is outperforming or lagging.

Tracking ZIVOW's current cash over time shows whether Zivo Bioscience- Warrants (29/04/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $110K That compares with $9.8K in the prior-year period — up 1058.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Zivo Bioscience- Warrants (29/04/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $110K) with ownership activity and broader fundamentals.

Zivo Bioscience- Warrants (29/04/2026)'s current cash is $110K; compare it with other Consumer Discretionary names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.